跳至主要内容
临床试验/ITMCTR2100005474
ITMCTR2100005474尚未招募1 期

Study on the real world and biological evidence of Xiaozheng Sanjie method in the treatment of chronic kidney disease based on traditional Chinese medicine flaccidity theory

The First Affiliated Hospital of Chengdu Medical College0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • ? Stage 3-4 patients who meet the diagnostic criteria specified in the 2012 KDIGO clinical practice guidelines for chronic kidney disease (CKD) (kidney international supplies. 2013,3:1-150.)
  • ? Age 18-75 years old.
  • ? The patient or his guardian has signed the informed consent before participating in the screening.

排除标准

  • ? Acute renal injury caused by various causes.
  • ? Patients with severe primary diseases such as liver and hematopoietic system, serious infection, mental abnormalities and malignant tumors.
  • ? Patients with renal replacement therapy such as hemodialysis, peritoneal dialysis and kidney transplantation.
  • ? Pregnant or lactating women under the age of 18 or over 75.
  • ? Other clinical trials are under way.

研究者

相似试验